Header Logo

Connection

JOHN FARMER to Hyperlipidemias

Back to Details
This is a "connection" page, showing publications JOHN FARMER has written about Hyperlipidemias.
JOHN FARMER
Connection Strength
0.979
Hyperlipidemias
  1. Intensive versus moderate lipid lowering with statins in acute coronary syndromes. Curr Atheroscler Rep. 2005 Mar; 7(2):85-6.
    View in: PubMed
    Score: 0.220
  2. Reversal of atherosclerosis with aggressive lipid lowering. Curr Atheroscler Rep. 2005 Mar; 7(2):86-7.
    View in: PubMed
    Score: 0.220
  3. Dyslipidemia and the vulnerable plaque. Prog Cardiovasc Dis. 2002 May-Jun; 44(6):415-28.
    View in: PubMed
    Score: 0.181
  4. Comparative tolerability of the HMG-CoA reductase inhibitors. Drug Saf. 2000 Sep; 23(3):197-213.
    View in: PubMed
    Score: 0.161
  5. Current and future therapeutic approaches to hyperlipidemia. Adv Pharmacol. 1996; 35:79-114.
    View in: PubMed
    Score: 0.117
  6. The Heart Protection Study: expanding the boundaries for high-risk coronary disease prevention. Am J Cardiol. 2003 Jul 03; 92(1A):3i-9i.
    View in: PubMed
    Score: 0.049
  7. Choosing the right lipid-regulating agent. A guide to selection. Drugs. 1996 Nov; 52(5):649-61.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.